If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 433.00
Bid: 428.00
Ask: 430.00
Change: 3.00 (0.70%)
Spread: 2.00 (0.467%)
Open: 422.00
High: 433.00
Low: 422.00
Prev. Close: 430.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acq of Ulster Bank tracker mortgage portfolio

1 Jun 2022 18:09

RNS Number : 6525N
AIB Group PLC
01 June 2022
 

 

 

1 June 2022

 

 

AIB Group plc confirms acquisition of Ulster Bank performing tracker mortgage portfolio

AIB Group plc ("AIB", the "Group") confirms that Allied Irish Banks, p.l.c. (1) has today entered into a binding agreement with NatWest Group plc and Ulster Bank Ireland DAC ("UIster Bank") for the acquisition of a performing Ulster Bank tracker (and linked) mortgage portfolio with an expected value of circa €5.7 billion(2) (the "Transaction"). This agreement has been reached further to the exclusive discussions that were announced on 29 April 2022 following a period of due diligence on the portfolio.

 

AIB will acquire the portfolio consisting of circa 47,000 Ulster Bank customers for a total consideration of €5.4 billion equivalent to 95.15% of par value, payable in cash funded from its existing resources. The exact consideration payable will depend on movements in the portfolio up to completion. AIB intends to engage a third party service provider to administer the portfolio on its behalf. This servicing arrangement will have no impact on customers who will retain their existing terms and conditions. The Transaction remains subject to obtaining any necessary customary regulatory approvals. AIB will acquire an economic interest in the mortgage portfolio in the second half of 2022 with formal completion expected in 2023.

 

The Transaction is expected to be accretive to earnings in 2023. On an annualised basis and inclusive of discount unwind, AIB expects total income of c. €90m and a 30bps average servicing cost. As required under IFRS 9, AIB will incur a Day 1 expected credit loss (ECL) charge as the portfolio migrates following formal completion.

 

AIB anticipates the Transaction to reduce CET1 by c. 70bps reflecting increased risk weighted assets of c. €2.5 billion(3). AIB's fully loaded CET1 at end March 2022 was 16.6% with a further 130bps CET1 reduction expected in relation to the agreed acquisition of Ulster Bank's corporate and commercial loans. The Transaction is also expected to be enhancing to RoTE in 2023, as AIB progresses towards its medium-term RoTE target of greater than 9% in 2023.

 

AIB Chief Executive, Colin Hunt, commented:

"We are delighted to have reached agreement with NatWest and Ulster Bank on another loan book acquisition and look forward to welcoming these customers to AIB. This acquisition further adds to our growing balance sheet and progress towards our strategic targets. Our strong capital position, which is well ahead of our medium-term target of >13.5%, enables us to invest in our business, pursue RoTE accretive inorganic opportunities and make distributions to shareholders."

 

 

[1] A subsidiary of AIB Group plc

[2] Portfolio size c. €6 billion at end March 2022

[3] Risk weighted assets may differ from what NatWest derecognise following the sale of assets

 

 

 

-ENDS-

 

For further information, please contact:

 

Niamh Hore / Siobhain Walsh

Paddy McDonnell / Graham Union

Investor Relations

Media Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-1-6411817 / +353 -87-3956864

Tel: +353-87-7390743 / +353-1-6412430

email: niamh.a.hore@aib.ie

email: paddy.x.mcdonnell@aib.ie

siobhain.m.walsh@aib.ie

Graham.x.union@aib.ie

 

 

 

 

 

 

Forward Looking Statements

 

This document contains certain forward looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking information. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements. These are set out in the Principal risks on pages 28 to 30 in the 2021 Annual Financial Report. In addition to matters relating to the Group's business, future performance will be impacted by direct and indirect impacts of the COVID-19 pandemic and by Irish, UK and wider European and global economic and financial market considerations. Any forward looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 28 to 30 of the 2021 Annual Financial Report is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward looking statement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUPUQUQUPPGMG
Date   Source Headline
9th May 20245:11 pmRNSHolding(s) in Company
9th May 20244:53 pmRNSHolding(s) in Company
8th May 202410:33 amRNSTotal Voting Rights
7th May 20245:36 pmRNSHolding(s) in Company
7th May 20247:00 amRNSHolding(s) in Company
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20246:01 pmRNSResult of Meeting
2nd May 20246:00 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Statement
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company
7th Nov 20237:08 amRNSAIB Group plc - Statement on State Divestment
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment
28th Jun 20237:00 amRNSResults of Secondary Placing in AIB Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.